BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37743116)

  • 1. Healthcare Workers (HCWs) and non-HCWs reaction to Bacillus Calmette-Guérin (BCG) in the BATTLE trial.
    Jalalizadeh M; Leme PAF; Buosi K; Dionato FAV; Dal Col LSB; Giacomelli CF; Reis LO
    Vaccine; 2023 Oct; 41(44):6599-6606. PubMed ID: 37743116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Bacillus Calmette-Guérin (BCG) strains in convalescent COVID-19 patients.
    Jalalizadeh M; Giacomelli CF; Leme PA; Buosi K; Dal Col LS; Dionato FA; Maia CL; Yadollahvandmiandoab R; Domingues-Junior AP; Reis LO
    Immunotherapy; 2023 Jan; 15(1):9-15. PubMed ID: 36628594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
    Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG;
    Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial.
    Claus J; Ten Doesschate T; Gumbs C; van Werkhoven CH; van der Vaart TW; Janssen AB; Smits G; van Binnendijk R; van der Klis F; van Baarle D; Paganelli FL; Leavis H; Verhagen LM; Joosten SA; Bonten MJM; Netea MG; van de Wijgert JHHM;
    mBio; 2023 Apr; 14(2):e0035623. PubMed ID: 36976004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial.
    Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH
    Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/
    Torun S; Ozkaya S; Şen N; Kanat F; Karaman I; Yosunkaya S; Sengoren Dikis O; Asan A; Aydogan Eroglu S; Semih Atal S; Ayten O; Aksel N; Ermiş H; Özçelik N; Demirelli M; Kara I; Sümer S; Marakoğlu K; Üzer F; Uyar Y; Çiçek T; E Ünsal Z; Vatansev H; Botan Yildirim B; Kuruoğlu T; Atilla A; Ersoy Y; Kandemir B; Durduran Y; Goksin Cihan F; Demirbaş N; Yıldırım F; Tatar D; Akcay MS
    Pathog Glob Health; 2021 Sep; 115(6):405-411. PubMed ID: 34014806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune response.
    Jalalizadeh M; Buosi K; Dionato FAV; Dal Col LSB; Giacomelli CF; Ferrari KL; Pagliarone AC; Leme PAF; Maia CL; Yadollahvandmiandoab R; Trinh QD; Franchini KG; Bajgelman MC; Reis LO
    J Intern Med; 2022 Oct; 292(4):654-666. PubMed ID: 35599154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil.
    Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC
    Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers.
    Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial.
    Dionato FAV; Jalalizadeh M; Buosi K; Visacri MB; Dal Col LSB; Giacomelli CF; Leme PAF; Maia CL; Moriel P; Reis LO
    Vaccine; 2022 Jul; 40(32):4603-4608. PubMed ID: 35738969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial.
    Koekenbier EL; Fohse K; van de Maat JS; Oosterheert JJ; van Nieuwkoop C; Hoogerwerf JJ; Grobusch MP; van den Bosch MAAJ; van de Wijgert JHH; Netea MG; Rosendaal FR; Bonten MJM; Werkhoven CHHV;
    Clin Microbiol Infect; 2023 Jun; 29(6):781-788. PubMed ID: 36736662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using BCG Vaccine to Enhance Nonspecific Protection of Health Care Workers During the COVID-19 Pandemic: A Randomized Controlled Trial.
    Madsen AMR; Schaltz-Buchholzer F; Nielsen S; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Azizi M; Hameed ZN; Johansen IS; Kofoed PE; Krause TG; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Oedegaard ES; Ostenfeld A; Soerensen MK; Wejse C; Netea MG; Aaby P; Benn CS
    J Infect Dis; 2024 Feb; 229(2):384-393. PubMed ID: 37774494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland-First Results.
    Czajka H; Zapolnik P; Krzych Ł; Kmiecik W; Stopyra L; Nowakowska A; Jackowska T; Darmochwał-Kolarz D; Szymański H; Radziewicz-Winnicki I; Mazur A
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of BCG Revaccination With
    Dos Anjos LRB; da Costa AC; Cardoso ADRO; Guimarães RA; Rodrigues RL; Ribeiro KM; Borges KCM; Carvalho ACO; Dias CIS; Rezende AO; Souza CC; Ferreira RRM; Saraiva G; Barbosa LCS; Vieira TDS; Conte MB; Rabahi MF; Kipnis A; Junqueira-Kipnis AP
    Front Immunol; 2022; 13():841868. PubMed ID: 35392074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
    Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM
    Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial).
    Pittet LF; Messina NL; Gardiner K; Orsini F; Abruzzo V; Bannister S; Bonten M; Campbell JL; Croda J; Dalcolmo M; Elia S; Germano S; Goodall C; Gwee A; Jamieson T; Jardim B; Kollmann TR; Guimarães Lacerda MV; Lee KJ; Legge D; Lucas M; Lynn DJ; McDonald E; Manning L; Munns CF; Perrett KP; Prat Aymerich C; Richmond P; Shann F; Sudbury E; Villanueva P; Wood NJ; Lieschke K; Subbarao K; Davidson A; Curtis N;
    BMJ Open; 2021 Oct; 11(10):e052101. PubMed ID: 34711598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19.
    Messina NL; Germano S; McElroy R; Rudraraju R; Bonnici R; Pittet LF; Neeland MR; Nicholson S; Subbarao K; Curtis N;
    Clin Transl Immunology; 2022; 11(4):e1387. PubMed ID: 35573165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.